Ignite Creation Date:
2024-05-05 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00145457
Status:
COMPLETED
Last Update Posted:
2007-06-06
First Post:
2005-09-01
Brief Title:
IGF1 Generation Test
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
A Multicentre Study on the Capacity of the IGF-1 Stimulation Test to Predict the Growth Promoting Effect of Standard and High Doses of Genotonorm in Prepubertal Children With Growth Hormone Deficiency
Status:
COMPLETED
Status Verified Date:
2007-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CAREL
Brief Summary:
To assess the predictive value of the short term IGF-1 stimulation test based on IGF-1 changes on the 24 months growth response to 2 different doses of GH in patients with conventional GH deficiency
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| A6281023 | None | None | None |